CLEC12A and acute myeloid leukemia: For example, two independent studies demonstrated that CAR-Ts specific for MICL exhibit potent cytotoxicity against MICL-expressing AML cell lines and primary AML samples without disrupting normal HSCs, and extend animal survival in a human xenograft mouse model (Tashiro et al, 2017; Laborda et al, 2017).